Market research
ADK.V DIAGNOS Inc
V CAD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 1.5
- Dividend yield
- Not available
- Beta
- 0.08
Profile
Instrument facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- CA2524423068
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 1.5
- Dividend yield
- Not available
- Beta
- 0.08
About
About DIAGNOS Inc
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
Research context
DIAGNOS Inc appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ADK.V discussion.
5 years, 6 months ago
DIAGNOS Inc is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.
From a valuation standpoint, the stock is 88.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 114.4.
DIAGNOS Inc's total revenue sank by 13.8% to $78K since the same quarter in the previous year.
Its net income has dropped by 0.9% to $-573K since the same quarter in the previous year.
Finally, its free cash flow grew by 27.3% to $-380K since the same quarter in the previous year.
Based on the above factors, DIAGNOS Inc gets an overall score of 2/5.